As part of the network, we operate an RNA synthesis platform to help collaborators access complex RNA structures.
Our Group is part of the newly started national NCCR initiative “RNA and Disease” (please click here (PDF, 586 KB)). We are collaborating with groups in Basel and Bern on projects related to:
- The role of Muscleblind (MBNL1) in miRNA biogenesis and its effects on myotonic dystrophy and cardiac dysfunction
- Splicing correction of the ferrochelatase gene for treatment of erythropoietic protoporphyria (EPP)
- Non-canonical mechanisms of miRNA – mRNA regulation.